4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-14-006089
Director sold 3,148 shares at $15.98 ($50,296)
- Director acquired 5,000 shares (option exercise)
- Director acquired 15,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
FRYKMAN EDWARD W · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-02-06 | Grant or award : show line 1 in the form | +15,000 | 22,000 | D | ||
| 2014-02-07 | Exercise or conversion : show line 2 in the form | +5,000 | $10.00 | $50,000 | 27,000 | D |
| 2014-02-07 | Sale : show line 3 in the form | −3,148 | $15.98 | $50,296 | 23,852 | D |
| Open-market sales · 3,148 sh · avg $15.98 · $50,296 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-02-07 | Exercise or conversion : show line 4 in the form Stock Option | −5,000 | 77,500 | D |
Loading xslF345X03/rrd402026.xml…